
Ventas VTR
$ 87.06
0.66%
Annual report 2025
added 02-06-2026
Ventas Interest Expense 2011-2026 | VTR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Ventas
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 612 M | 603 M | 574 M | 468 M | 440 M | 470 M | 452 M | 442 M | 448 M | 420 M | 367 M | 292 M | 249 M | 289 M | 224 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 612 M | 224 M | 423 M |
Quarterly Interest Expense Ventas
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 150 M | 149 M | - | 150 M | 149 M | 150 M | - | 148 M | 143 M | 128 M | - | 119 M | 114 M | 111 M | - | 109 M | 110 M | 111 M | - | 116 M | 123 M | 117 M | - | 114 M | 110 M | 111 M | - | 108 M | 113 M | 111 M | - | 114 M | 114 M | 109 M | - | 105 M | 104 M | 103 M | - | 97.1 M | 84 M | 82.3 M | - | 77.3 M | 91.5 M | 87.8 M | - | 83.8 M | 82.2 M | 78.6 M | - | 74 M | 72.8 M | 68.1 M | - | 69.5 M | 52 M | 41.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 150 M | 41.7 M | 106 M |
Interest Expense of other stocks in the Reit healthcare industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Global Medical REIT
GMRE
|
19.7 M | - | - | $ 2.37 B | ||
|
Sabra Health Care REIT
SBRA
|
9.36 M | $ 20.21 | -1.03 % | $ 4.88 B | ||
|
The GEO Group
GEO
|
161 M | $ 15.11 | 0.3 % | $ 2.08 B | ||
|
LTC Properties
LTC
|
27.4 M | $ 38.73 | -1.92 % | $ 1.79 B | ||
|
National Health Investors
NHI
|
59.9 M | $ 85.01 | -2.05 % | $ 3.73 B | ||
|
Omega Healthcare Investors
OHI
|
122 M | $ 47.3 | -0.34 % | $ 13.8 B | ||
|
Healthpeak Properties
PEAK
|
305 M | - | 2.09 % | $ 9.35 B | ||
|
Welltower
WELL
|
-41.7 M | $ 207.29 | -0.38 % | $ 138 B |